arrow
E

Ersilia Lucenteforte

statistics
H指数:44
被引数:8,628

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

SodiuM glucose cotrANsporter-2 (SGLT-2) inhibitors in the treatment of type II DiAbetes in Tuscany: utiLizatiOn patteRns; and relatEd clinical use evaluation; the MANDALORE study protocol

钠葡萄糖协同转运蛋白-2 (SGLT-2) 抑制剂在托斯卡纳地区治疗II型糖尿病中的应用模式及相关临床使用评估;MANDALORE研究方案

2026-04-030
OAAI
Trajectories of Adherence to Biologics in Patients With Inflammatory Bowel Diseases: A Large-Scale Multi-Regional Italian Study Through the VALORE Distributed Database

炎症性肠病患者对生物制剂的依从性轨迹:一项基于VALORE分布式数据库的大型多区域意大利研究

2025-10-010
OAAI
International Trends in Opioid Prescribing by Age and Sex from 2001 to 2019: An Observational Study Using Population-Based Databases from 18 Countries and One Special Administrative Region

2001年至2019年按年龄和性别划分的阿片类药物处方国际趋势:一项使用来自18个国家和一个特别行政区的基于人群的数据库的观察性研究

2025-09-010
OAAI
Effectiveness of a targeted infant RSV immunization strategy (2024–2025): A multicenter matched case-control study in a high-surveillance setting

针对婴儿RSV的靶向免疫策略有效性(2024–2025):一项在高监测环境下的多中心匹配病例对照研究

2025-08-210
OAAI
Normal ranges of tissue Doppler imaging echocardiographic parameters in healthy term and preterm newborns: a systematic review and meta-analysis

组织多普勒成像超声心动图参数在健康足月和早产新生儿中的正常范围:一项系统综述和荟萃分析

2025-08-140
OA
Defining replicability and evaluating reliability of intra-operative cytological bone margins assessment. A study to strengthen previous findings in advanced oral cancer

定义可重复性并评估术中细胞学骨切缘评估的可靠性。一项旨在加强晚期口腔癌先前发现的研究。

2025-07-050
PRE
Trajectories of biologic drug use before, during and after pregnancy: an Italian cohort study from the VALORE project
2024-12-210
OA
A multidisciplinary non-invasive approach to monitor response to intravenous immunoglobulin treatment in neurodegenerative Langerhans cell histiocytosis: a real-world study

多学科非侵入性方法监测神经退行性朗格汉斯细胞组织细胞增生症对静脉注射免疫球蛋白治疗的反应: 一项真实世界研究

2024-08-160
OAAI
Risk of Intraocular Pressure Increase With Intravitreal Injections of Vascular Endothelial Growth Factor Inhibitors: A Cohort Study
2023-04-0113
PRE